February 2, 2015 / 4:22 PM / 3 years ago

BRIEF-Amphion Innovations says Motif Bio to trade on AIM

Feb 2 (Reuters) - Amphion Innovations Plc

* Reissue: partner company's intention to float

* Motif Bio Limited , has today announced its intention to raise at least 4 million pounds through a placing of new ordinary shares and admission to trading on AIM

* Discussions and negotiations with academic institutions and pharmaceutical companies are under way to build a portfolio of antibiotic candidates through licensing

* Directors anticipate that iclaprim could be ready for commercialisation within approximately 36 months

* As of 31 December 2013, Amphion owned 32% of motif Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below